Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial

OBJECTIVE: To evaluate the impact of once-weekly exenatide (EQW) on microvascular and cardiovascular (CV) outcomes by baseline renal function in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL). RESEARCH DESIGN AND METHODS: Least squares mean difference (LSMD) in estimated glomerular fi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Diabetes Care
Asıl Yazarlar: Bethel, M. Angelyn, Mentz, Robert J., Merrill, Peter, Buse, John B., Chan, Juliana C., Goodman, Shaun G., Iqbal, Nayyar, Jakuboniene, Neli, Katona, Brian, Lokhnygina, Yuliya, Lopes, Renato D., Maggioni, Aldo P., Ohman, Peter, Tankova, Tsvetalina, Bakris, George L., Hernandez, Adrian F., Holman, Rury R.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Diabetes Association 2020
Konular:
Cardiovascular and Metabolic Risk
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7411285/
https://ncbi.nlm.nih.gov/pubmed/31757838
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc19-1065
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller